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 ABSTRACT 
INTERACTIONS BETWEEN FMRI BOLD-ACTIVATION DURING READING 
TASKS AND MRS-MEASURED METABOLITE LEVELS. 
Hassana Aisha Ibrahim, Stephen Frost, Kenneth Pugh, Robert Fulbright.  Section of 
Neuroradiology, Department of Radiology, Yale University School of Medicine, New 
Haven, CT.  
 
Recent studies in the field of dyslexia have used magnetic resonance spectroscopy 
(MRS) to explore neurochemical manifestations of neurobiological differences in the 
brains of dyslexic adults compared to controls.  This study examines the potential 
relationship between functional magnetic resonance imaging (fMRI) BOLD (blood 
oxygen level demand) activation scores in response to cognitive tasks and MRS-
measured levels of a metabolite and a neurotransmitter, N-acetylaspartate (NAA) and 
gamma-aminobutyric acid (GABA) respectively, in the occipital region of brains of 
seven-year old children.  Preliminary results from this multi-arm, longitudinal study 
indicate a significant positive correlation between fMRI BOLD signal elicited in response 
to picture-cues in the occipital region of interest bilaterally, and both GABA (R2=0.477 
p=0.05, 2-tailed) and NAA (R2=0.587 p=0.01, 2-tailed) levels. The results suggest that 
the functional neuroanatomical circuitry involved in a cognitive task also has 
neurochemical indicators. 
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INTRODUCTION 
Background 
Developmental dyslexia, the most common learning disability, is a disorder 
characterized by an impairment in reading abilities, which is not explained by deficits in 
intelligence, learning resources, socio-cultural opportunities or sensory acuity (1).  
Although there are several theories regarding its etiology, it is widely accepted as arising 
from a core deficit in phonologic processing (2, 3, 4).  The neurobiological basis of the 
disorder has been explored through various approaches including from physiological, 
anatomical, genetic, and recently biochemical standpoints. 
From a neurophysiological standpoint, using functional magnetic resonance 
imaging (fMRI), positron emission tomography (PET) and electrophysiology, studies 
have shown that compared to controls who show left planum temporale, perisylvian 
region (including the superior and medial temporal gyri) and left temporo-occipital 
activity lateralization in response to phonologic tasks (5), dyslexic children show a more 
diffuse response to such tasks (4, 6) and in some studies even a right hemispherical 
lateralization (7). In addition, Shaywitz et al. (8) found relative under activation in 
posterior regions (Wernicke's area, the angular gyrus, and striate cortex) and relative over 
activation in an anterior region (inferior frontal gyrus) in dyslexics compared to controls 
in response to phonologic tasks using fMRI.  Paulesu et al. (9) found using PET a lack of 
concerted Broca’s and temporo-parietal cortical activation during phonologic tasks in 
dyslexics compared to controls, and also a complete lack of insula cortex activation.  The 
findings led the Paulesu group to hypothesize a dysfunctional connection between 
anterior and posterior language regions in dyslexics.  
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Neuroanatomic findings in dyslexics using neuroimaging and post-mortem 
analysis have included reduced volume of the posterior language area (10), cerebellar 
anatomic differences (11), symmetry of the usually asymmetric planum temporale 
(although more recently challenged), dysgenesis and glial scarring of the inferior 
temporal gyrus (12)  
As dyslexia tends to run in families, various candidate genes have been evaluated 
for heritability of the disorder (13, 14, 15).  More than 30% of adults with developmental 
dyslexia report that at least one of their offspring manifested reading problems.  
Monozygotic twins also display almost twice the concordance in the diagnosis of 
developmental dyslexia than dizygotic twins (16).  
Although relatively fewer studies have been conducted to explore biochemical 
differences between dyslexics and controls, nonetheless, these studies have found various 
dissimilarities in metabolites and neurotransmitters. Using magnetic resonance 
spectroscopy (MRS), Rae and others (17) found significant differences between dyslexic 
men and controls in ratios of choline-containing compounds (Cho) to N-acetylaspartate-
containing compounds (NAA) (p<0.01) in the left-temporo-parietal lobe and Cho to 
creatinine-containing compounds (Cr) in the cerebellum.   Specifically, there was a 
decreased Cho/NAA ratio in the left temporo-parietal lobe, no difference in Cr/NAA 
ratio, and also a decreased Cho/Cr ratio (non-significant) in dyslexic men compared to 
controls, suggesting that the decrease in the Cho/NAA ratio was from a decrease in Cho.  
There was also a significant and relatively lower Cho/NAA ratio in the left temporo-
parietal lobe of dyslexics compared to the right (p<0·02), which was lacking in controls.  
As hypothesized by previous authors concerning neuroanatomical differences (12), the 
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Rae et al group also suggests that the observed neurobiochemical differences reflect 
changes in cell density.  They further hypothesize that it is a result of abnormal 
development of cells or intracellular connections or both.   
A study by Richardson et al., using 31P-MRS in 1997 (18), found significant 
elevation in phosphomonoester (PME) peak area in dyslexics; consistent with a 
hypothesis that membrane phospholipid metabolism is abnormal in dyslexia. The PME 
peak predominantly consists of phosphoethanolamine (PE) and phosphocholine (PC), 
which are precursors of membrane phospholipids. And in 1999, Richards et al. (19), 
found that dyslexic children differ from controls in brain lactate metabolism when 
performing language tasks, but not in non-language auditory tasks. Other studies by 
Richards et al. (20) have examined changes in metabolite levels following behavioral 
interventions in children with dyslexia.  Their group found that prior to therapeutic 
intervention, the dyslexic group showed a significantly greater increase in lactate levels 
in the left frontal regions (including inferior frontal gyrus) during phonologic tasks. After 
treatment, the dyslexic group did not differ significantly from the control group in lactate 
levels in any brain region during tasks, but found that the treatment effect was due to the 
morphologic component of the tasks, rather than the phonologic component.   
The importance of metabolite differences lies in their use as a tool reflective of 
different brain cells and/or structures.  For example, the concentration of Cho is higher in 
white matter than in grey matter, and higher in glial cells than in neurons, whereas NAA 
occurs primarily in neuronal cells and is a marker of neuronal-cell density and neuronal-
mitochondrial activity in the brain.  These correlations have been confirmed by 
histochemical and cell-culture studies (17).  NAA has been associated with lower IQ in 
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such disorders as mental retardation and temporal lobe epilepsy.  White matter NAA has 
also been related to broad measures of cognition in normal young and elderly subjects, 
implicating NAA as a sensitive marker of brain–behavior relationships (21).  
In addition to metabolites, neurochemicals that function as neurotransmitters are 
also important potential candidates for understanding the biochemical manifestations of 
neurobiological disorders.  GABA is an inhibitory neurotransmitter that has been 
previously linked to epileptic seizures, among other neurological diseases.  In the context 
of reading disabilities, various GABA-modulating drugs have been shown to affect 
performance in learning tasks in rodents (21, 22). There is also growing evidence 
supporting a hypothesis that the GABAergic (and cholinergic) system plays a key role in 
neuronal plasticity necessary for repetition adaptivity (24).  Coupled with the fact that a 
number of GABA gene mutations have been found in the susceptibility region for 
dyslexia (25; 26), GABA appears to be a suitable neurotransmitter candidate for reading 
disabilities.  In a recent study by McLean et al. (27), the authors successfully measured in 
vivo levels of GABA using MRS and established a control range of GABA levels in the 
occipital lobes of volunteer participants. 
As discussed above, a number of interrelated neural systems have been proposed 
as key in reading ability.  One such system has been proposed in the left occipital-
temporal region.  It is hypothesized as a rapidly processing reading system that is 
important for the development of skilled reading, functioning as an automatic, instant 
word-recognition system. In addition, brain activation in this region increases as reading 
skill increases (28).  The MRS arm of this study focuses on an occipital region as the 
region of interest for the MRS voxel. Ideally, the MRS voxel would be placed in both left 
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and right regions for comparison, however, for practical purposes, the ROI will be chosen 
in a central location, described further in the methods section. 
The information gathered from using a non-invasive modality such as MRS is 
important not only to better understand the neurobiology, but also as a platform to design 
and monitor therapeutic interventions.  Also importantly, majority of studies on reading 
disability have been conducted using adult dyslexics, and the relative safety and non-
invasiveness of MRS and fMRI permits easier recruitment of pediatric subjects for 
studies, improving the ability to establish the neurobiological etiology of dyslexia, and 
increases the possibility of earlier intervention.   
 
STATEMENT OF PURPOSE AND HYPOTHESIS 
The study is part of a multi-dimensional, longitudinal project (by the Yale 
University School of Medicine Neuroradiology section of the Department of Radiology, 
Yale Reading Center and Haskins Laboratories) using MRS, fMRI, genetic and 
behavioral analysis to examine reading disability.  The preliminary result presented in 
this thesis explores interactions between both NAA and GABA levels in the occipital 
region of interest as measured using MRS, and fMRI BOLD activation scores in response 
to picture processing.  
 We hypothesize a correlation between MRS-measures of GABA, NAA and 
BOLD activation scores and also between GABA and NAA levels, and that these values 
will affect reading performances over time. 
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Introduction to MR 
Before presenting and discussing the results of this study, the basis of magnetic 
resonance will be reviewed to better understand the data and also the strengths and 
limitations of clinical MRS and fMRI. 
Without doubt, the concept of magnetic resonance (MR) has revolutionized 
medical diagnosis.  This is more commonly thought of as magnetic resonance imaging 
(MRI), however, nuclear magnetic resonance spectroscopy (NMR) or magnetic 
resonance spectroscopy (MRS) is another application that is increasingly being 
appreciated and applied in diagnostic medicine. The concept of MR has been applied in 
basic science laboratories for decades to identify chemical compounds and analyze 
molecular interactions, however it was only first used for imaging humans in the 1970s.  
And by the late 1980s, MRI had become the popular modality for assessing neurological 
disorders and evaluating vascular flow (29). In addition to its employment in identifying 
compounds and defining structures, one of the greatest appeals of MR modality in 
medicine lies in its use of non-ionizing radiation, thereby avoiding the more destructive 
nature of comparable imaging modalities such as computed tomography (CT). 
Both MRS and MRI essentially employ similar principles of MR. Whereas MRI 
uses the signal obtained to generate an image; MRS generates a frequency domain 
spectrum of the components of the object (30). From the image generated in MRI, 
structural anomalies can be detected, providing useful information about diseases.  MRS 
on the other hand provides biochemical information about pathology and may lend a 
better understanding of underlying pathological processes. Unlike MRI, which primarily 
observes hydrogen nuclei to obtain information about water and fat constituents of tissue, 
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MRS provides information on the nature and concentration of non-water protons present 
in metabolites and chemicals present in tissues.  Although 1H is highly abundant in 
organic compounds, the 1H MR spectral range is very narrow and signal obtained usually 
contains undesired noise signals from other molecules. However, MRS can also 
interrogate other nuclei such as 13C, 15N, 19F and 31P (31).  These nuclei are also 
important components of organic compounds.  For instance, nitrogen is found in proteins 
and deoxyribonucleic acid (DNA), and carbon is a crucial component of organic 
compounds. However, signals from such nuclei are usually obtained from molecules with 
much less concentration than water in tissues, and consequently one of the limitations of 
MRS is that spectra have to be acquired from relatively large volumes of tissue (>1cm3) 
compared to MRI.    
fMRI is a newer brain mapping technique that was first used in human 
experiments in the early 1990s.  It is based on MR and uses rapid imaging techniques to 
demonstrate regional blood flow changes in space and time in response to performance of 
various sensorimotor and cognitive tasks. The fMRI phenomenon is actually dependent 
on tissue fluctuations of paramagnetic deoxyhemoglobin and diamagnetic 
oxyhemoglobin, which causes changes in magnetic susceptibility.  It is assumed that 
blood flow changes provide an indirect measure of brain activity based on neurovascular 
coupling, i.e. increased blood flow in response to increased neural activity. fMRI 
provides excellent spatial resolution, enabling matching of blood flow changes to specific 
anatomic structures (29). The differences in MR signal intensity between two conditions 
are typically presented as a color scale, representing statistical significance, either 
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displayed over the original images or superimposed over a high-resolution anatomic 
image (32) 
 Recent improvements in hardware and measurement techniques have also 
contributed in making in vivo clinical MR studies practical by providing an acceptable 
signal/noise (S/N) ratio without unbearably prolonging patient time in the scanner, and 
also streamlining processing of data. 
Basic science of MR 
Magnetic resonance probes atoms and molecules based on their interaction with 
an external magnetic field (31).  It primarily relies on one of the characteristics of an 
atom – its nuclear spin.  To review, an atom is composed of protons and neutrons (which 
make up the core nucleus) and electrons (which surround the nucleus).  All atoms of an 
element have the same atomic number, i.e. the same number of protons in the nucleus.  
They can however differ in the atomic weight and are referred to as isotopes.  The 
difference in weight is essentially due to differences in number of neutrons, as electrons 
contribute relatively little to atomic weight.  This elemental characteristic is also 
important because the relative abundance of various isotopes affects the way the nucleus 
of an element can be examined using MRS.   
As mentioned above, the intrinsic motion of an atom - its nuclear spin is 
necessary for the concept of magnetic resonance.  This spin can be described using 
quantum mechanics or classical mechanics.  Classical mechanics assumes that a moving 
object being studied is a point particle, with negligible size, and its motion can be 
described by its position, mass and external force being applied to it.  This often suffices 
when describing larger size objects e.g. atomic level and larger, but becomes inaccurate 
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when examining objects at sub-atomic levels.  Quantum mechanics is a modern 
mathematical theory, which provides a more complete, accurate and precise description 
of elemental properties on atomic and sub-atomic levels, albeit more complex as 
compared to classical mechanics.  The term quantum refers to the assumption that certain 
physical properties can only assume discrete quantities, as in the case of nuclear spins.  
The quantum mechanics theory states that the discrete and quantized nuclear spin 
value is either zero (i.e. no spin), integer (e.g. 1, 2, etc) or half-integer (e.g. 1/2, 3/2, etc).  
A zero spin value is a result of an atom having an even number of protons and neutrons 
e.g. 12C, and as such cannot be studied using MR. An integer value is found in an atom 
with an odd number of protons and neutrons e.g. 2H, while a half-integer value is found 
in an atom with an even number of protons and odd number of neutrons or vice versa e.g. 
1H.  The half-integer spin value is the most commonly encountered in clinical 
spectroscopy, but both whole and half-integer values provide a nucleus a magnetic field.  
This magnetic field can be likened to a bar magnet with a magnitude (i.e. integer or half-
integer) and orientation (i.e. north and south poles).  The nuclear magnetic field can be 
measured to obtain information about that molecule and its surroundings.  This is done 
indirectly by manipulating the nuclear spin with a radiofrequency (RF) pulse, and 
measuring the resulting voltage.   
  To further explore why the radiofrequency pulse manipulation is necessary, 
consider a volume of tissue outside a magnetic field containing various nuclei, but all 
having a nuclear spin magnitude of 1/2.  Although each nucleus behaves like a tiny 
magnet, the net magnetization of the tissue is zero. This is because the nuclear 
magnetization effectively cancel each other out because they are oriented randomly i.e. 
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+
1/2n + -1/2n = 0 (where n = number of nuclei in that orientation).  If the same tissue is 
placed in a magnetic field, Bo, of a given magnitude and axis of orientation, the 
individual nuclei spins will start to rotate parallel to the axis of orientation of the external 
magnetic field.  They will however be slightly tilted away (precess) from the axis of the 
magnetic field because of the continuous interaction between the moving nuclear spins 
and the external magnetic field.  An analogy of precession is the wobbling of toy tops as 
they spin. 
Each nuclear spin has a z-axis component, which is parallel to that of the external 
magnetic field Bo, and constant with time, and x- and y-axis components referring to its 
precession, which is constantly changing and perpendicular to the external magnetic field 
(31).  The Larmor equation relates the strength of the magnetic field Bo to the rate of 
precession as follows:  
ωo = γBo /2π 
Where, ωo = Larmor frequency in Megahertz (MHz), Bo is the magnetic field strength 
that the spin experiences in tesla (T) and γ is the gyromagnetic ratio, a constant for each 
nucleus in units of reciprocal seconds, reciprocal tesla (s-1T-1).    
 When an external magnetic field is applied on a magnetic dipole, in this case the 
“nuclear magnet”, it will exert a rotational force (torque) and result in magnetic potential 
energy. The Zeeman interaction defines the possible values of the resultant energy states 
of the nuclear spin, in the z-axis.  For a given magnitude of spin, I, the possible values of 
the z component is equal to 2I + 1, symmetrically divided about 0.  In addition, the 
difference in z component values between adjacent orientations is equal to +1 or –1 (31).  
Therefore, for example a spin magnitude of 1/2 has only two possible values of the z 
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component, +1/2 and –1/2, also known as spin up (parallel) and spin down (antiparallel) 
respectively.  A similar interaction occurs for energy levels, where for most nuclei, the 
lowest energy state is at the largest positive z component (i.e. parallel to Bo) and the 
highest possible energy state corresponds to the largest negative z component (i.e. 
antiparallel to Bo).  The difference in energy level between each consecutive state is 
proportional to Bo, and the corresponding frequency is the Larmor frequency of the spin.  
And if energy is applied to the nucleus at the Larmor frequency (also known as the 
resonant frequency), the spin will go from one energy level to another through a process 
known as resonance absorption.   
 As the spins examined in clinical MRS are usually from a bulk of tissue, rather 
than individual nuclei, the Boltzmann distribution is useful in describing the energy states 
of a collection of spins: 
Ni = Ntotal e (-Ei/kT) 
Where Ni is the number of spins in state I, which has energy, Ei in Joules (J), Ntotal is the 
total number of spins in the volume, k is the Boltzmann’s constant (1.381 x 10 –23 J K-1) 
and T is the absolute temperature in Kelvin (K).  This relationship indicates that the 
largest number of spins will be in the lower energy states with gradually reduced numbers 
in higher energy states.   
 If an RF pulse is applied to a collection of spins, majority of spins (those in a 
lower energy state) will absorb energy, while a minority (those is a higher energy state) 
will emit energy.  The RF pulse is applied at a frequency ω1 (central frequency) and 
oriented at a magnetic field of B1 (which is perpendicular to Bo). If the RF pulse is 
applied at the Larmor frequency (ωo), the net magnetization of the tissue (Mo) will rotate 
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away from its equilibrium orientation towards the transverse plane.  And if applied long 
enough at the right amplitude, Mo will rotate completely to the transverse plane.  This 
transverse plane is perpendicular to both Bo and B1, and such an RF pulse is known as a 
90o pulse.   
When the RF pulse is discontinued, the spins will return to their original 
orientation and energy state, and will emit energy at the Larmor frequency, ωo, in the 
process.  During this precession, a voltage is emitted in the transverse place, and can be 
measured by a loop of wire in that plane.  The magnitude of the voltage is dependent on 
the value of Mo immediately prior to the 90o pulse and it will decay with time through a 
process known as relaxation.  This voltage is the MR signal, and is known as free 
induction decay (FID).   
It is important to remember that in a tissue sample, each individual spin will 
experience its own magnetic field; hence several voltages (MR signals) at different 
frequencies will be obtained following an RF pulse.  Therefore, the FID of a tissue 
sample actually contains many superimposed frequencies as a function of time.  In order 
to separate the individual frequencies, the amplitude of the voltage can be expressed as a 
function of frequency, rather than time (FID).  This is done via a mathematical process 
called Fourier transformation.  
 In addition, each voltage wave can be defined in terms of phase, i.e. its frame of 
reference or position in the cycle, along the time domain.  Most MR receivers examine 
two phases; one with the reference signal in phase with the original transmitter, and the 
other 90o shifted in phase.  These signals are called the real (dispersion) and imaginary 
(absorption) channels respectively.  The Fourier transformation actually produces spectra 
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containing a mixture of these two phases/modes; therefore, a process known as phase 
correction is employed. This enables further analysis to be performed on each spectrum, 
more commonly the absorption spectrum. 
 So how does one interpret the spectrum?  There are three characteristics of the 
spectrum that are of utmost interest: the integrated area, position (resonant frequency), 
and width of each resonance peak.  The peak area is proportional to the number of spins 
contributing to the MR signal.  The x-axis peak position has information about the type of 
spin and its molecular environment, reflecting the degree of “chemical shift” of the 
molecule. This is usually time independent, but can also vary with time.  The third 
characteristic of interest, the width, conveys information about whether the signal is from 
one type of spin, or multiple types.  This is most accurately performed by determining the 
shape of the spectral peak.  Most tissue MR spectra are composed of two types of line 
spectra shape, Lorentzian and Gaussian.  Lorentzian shapes have very broad bases, and 
are such that the line width [half-width at half-maximum height (hwhm)] is inversely 
proportional to the total transverse relaxation time, T2*.  These are usually from spins in 
a single molecular environment.  Gaussian line shapes on the other hand, are observed 
when multiple spins with very similar environments contribute to the resonance.   
Time-independent MR modifiers: chemical shift, spin coupling 
Thus far, the nuclear magnetic field has been described by its relationship to an 
applied magnetic field of known magnitude. However, the total magnetic field 
experienced by a nucleus is modified by the currents induced by electrons present in 
orbits around the nucleus, a concept referred to as chemical shift.  As such, there can be 
variations in NMR frequencies of the same type of nucleus, due to differences in electron 
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distribution in different molecules e.g. from different bond lengths, bond angles, binding 
patterns.  Chemical shift is usually expressed in parts per million (ppm), and is calculated 
from the difference in precession frequency between two nuclei (hertz) divided by the 
Larmor frequency of the magnet (Megahertz).  The size of the chemical shift is given 
with respect to a reference frequency, usually a molecule with a barely distorted electron 
distribution, such as tetramethylsilane (TMS).  For example, lactate (methyl group) has a 
chemical shift of 1.3 ppm, 2.0 ppm for NAA (methyl group) and 4.7 ppm for water, all 
relative to TMS.  
Another important time-independent modifier in magnetic resonance frequency is 
spin coupling.  This refers to the sub-division of a peak from a single proton into multiple 
peaks on the NMR spectrum as a result of interaction with nearby nucleic spins within a 
molecule.  This splitting of NMR lines conveys more detailed information about the 
structure of molecules.   Spin-spin coupling or J coupling is a sub-type of spin coupling, 
which denotes facilitation by nearby electrons.  Spin-spin coupling is different from 
chemical shift, because the former is independent of magnetic field strength and always 
involves another spin, while the latter is altered by magnetic field strength.  The number 
of multiple peaks (multiplets) arising from a proton is proportional to the number of 
similar protons connected by double or triple bonds to the proton being observed (31). 
Time-dependent MR modifiers: relaxation, spin echo 
Relaxation and spin echo are two examples of important time-dependent 
interactions in MR. As described earlier, nuclei with spins in lower energy states absorb 
energy or become “excited” when an RF pulse is applied.  Relaxation describes the 
release of the absorbed energy and return of the nuclei to their original states.  This 
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energy release can be measured in longitudinal and transverse directions, involving T1 
and T2 time constants respectively.  T1 relaxation time is the time required for the z 
(longitudinal) component of the magnetic field (M0) to return to 63% of its original 
energy value following excitation, and it follows an exponential curve.  T1 is also known 
as spin-lattice relaxation time because this relaxation generally occurs by interactions 
between the nuclei of interest and their environment or “lattice,” consisting of unexcited 
nuclei and electric fields in the surroundings.  Transfer of energy from excited nuclei to 
the lattice is facilitated by having unexcited nuclei with similar intrinsic frequency to that 
of the resonant frequency.  There is less discrepancy in these frequencies when 
macromolecules such as proteins with slower tumbling rates (lower frequencies) are 
considered, than in smaller molecules with faster tumbling rates such as metabolites.  
Hence protein nuclei generally have shorter T1 values than metabolites.   At a field 
strength of 1.5 Tesla (T), lactate (methyl group) and NAA (methyl group) metabolites 
from brain occipital lobe have T1 values of 1.55s and 1.45s respectively (31). 
T2 relaxation time is the time required for the transverse component of the 
magnetic field (M0) to return to 37% of its initial value following excitation, via 
irreversible processes.   As this is perpendicular to the ambient magnetic field, the decay 
occurs mainly due to interactions between the nuclei of interest and other excited nuclei.  
Hence T2 is also known as spin-spin relaxation. Immediately following a 90o RF pulse, 
spins will absorb energy, orient in the transverse plane, align in the same phase and 
precess at the same frequency.  This precession at the same frequency and phase 
facilitates energy transfer between adjacent nuclei, rather than to their environment (as in 
T1). However, an irreversible loss of transverse magnetization signal eventually occurs 
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because of local microscopic field inhomogeneities. An example is the fluctuation as a 
function of time of the local fields produced by electrons of molecules in motion relative 
to the spin of interest (33).  At a field strength of 1.5 tesla (T), lactate (methyl group) has 
a T2 value of 1040ms. 
T2 does not take into account the intra-voxel dephasing that occurs due to 
macroscopic field inhomogeneities.  This dephasing results in a much faster decrease in 
transverse magnetization, T2*, via free induction decay than predicted by T2.  T2* like 
T2, measures the time it takes for the transverse magnetization to decay to almost zero, 
but takes into account the faster decay resulting from dephasing.  As such, T2* is often 
referred to as the true “relaxation” time and is always less (shorter) than the T2 relaxation 
time. Both T2* and T1 are also greatly influenced by variations of field strength, unlike 
T2 (33). 
Sequences that accentuate T1 decay are generally referred to as T1-weighted 
images and those that accentuate T2 relaxation are referred to as T2-weighted images. A 
combination of these is usually employed in brain MR scans, as some abnormalities may 
be better displayed on one versus the other. Fluid such as cerebrospinal fluid is generally 
very bright on T2-weighted images and dark on T1-weighted scans. Whereas fat is bright 
on T1-weighted images and dark on T2-weighted images. The intensity of brain tissue is 
somewhere in the middle, and the intensity of blood vessels varies depending on velocity 
of blood flow (29). 
Spin echo refers to a maximal MR signal obtained when all the spins in a volume 
of interest have the same phase. This is obtained by applying a second rf pulse at 180o at 
a later time, following the initial 90o rf pulse, resulting in refocusing or rephasing of the 
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spins. A common analogy is by considering two runners A and B, who begin running at 
time zero from the same starting point in the same direction along the y-axis, at speeds of 
10 miles/hour and 20 miles/hour respectively.  If both runners are stopped after an hour, 
A will be at +10 miles and B will be at +20 miles along the y-axis.  However, if they are 
both allowed to run back toward the original starting point at previous respective speed 
along the y-axis, after an hour, both runners A and B will be back at the starting point.  
This illustrates that regardless of the local field inhomogenities that cause spins to precess 
at different rates, the spins are refocused following the 180o pulse.  Gradient echo unlike 
spin echo is obtained through application of a specifically calculated excitation pulse that 
removes necessitation of a rephasing rf pulse. There are differences in quality and 
contrast of images obtained using different approaches (34). 
Localization techniques: STEAM, PRESS 
Stimulated echo acquisition mode (STEAM) and point-resolved spectroscopy 
(PRESS) are two single-volume localization techniques employed in MRS. STEAM 
sequence is a form of spin echo which uses an initial excitation rf pulse (classically 90°, 
but could be anything other than 180o), followed by two rf pulses (classically 90°, 90°), 
producing the stimulated echo after a time delay (equal to the interval between the first 
two pulses) following the 3rd pulse.  The intensity of the resultant echo is partly 
dependent on the T1 relaxation time because the excitation is 'stored' as longitudinal 
magnetization.  PRESS uses a 90° rf pulse, followed by two 180o pulses. The 90° rf pulse 
rotates the spins in the yx-plane, followed by a 180° pulse in the xz-plane and another 
180° pulse in the xy-plane, producing the echo.  STEAM uses a shorter TE, has better 
suppression of water, and thus allows for visualization of more metabolites including 
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myoinositol, glutamate, glutamine, and GABA.  PRESS on the other hand uses a longer 
TE and results in loss of signal from most brain chemicals except NAA, creatinine, 
choline-containing phospholipids, and lactate; however, it is not as susceptible to motion, 
diffusion, and quantum effects and has a better signal to noise ratio than STEAM.  
Reduction of external magnetic field inhomogeneities: shimming 
Shimming is a technique of correcting the inhomogeneities of the external 
magnetic field caused by intrinsic imperfections of the primary magnet or from other 
ferromagnetic objects present in the surroundings.   It is done most commonly by using 
shim coils and making changes to their currents while obtaining the Fourier transform 
signal. 
Clinical applications of MRS, fMRI 
 Currently, MRS (specifically 1H) of the brain is the most commonly performed 
MRS patient examination. The brain is an ideal target organ for MRS compared to other 
organs because of more favorable characteristics, such as less motion artifact, relative 
ease of shimming, and lack of detectable (i.e. mobile) lipids in normal brain tissue. (31). 
Brain MRS studies have focused on metabolites such as N-acetyl aspartate 
(NAA), which is a neuronal marker; choline, an indicator of cell membrane turnover; 
creatine, a marker for energy metabolism; and lactate, a marker for anaerobic 
metabolism. Clinical CNS applications of MRS have included evaluations of tumors 
post-surgical resection to assess for residual or recurrent cancerous tissue (29). It is 
mostly used as an adjunct to MRI. 1H MRS has also been used to monitor treatment in 
patients undergoing chemotherapy for leukemia, by examining lumbar vertebral body 
bone marrow fat. Some studies have suggested future applications of MRS in assessment 
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of muscle disease by comparing signals from fat peaks and relative water/fat 
concentration (31).  
Clinical applications of fMRI have included presurgical mapping of important 
eloquent brain regions, to guide decision of candidacy for surgical resection of adjacent 
abnormal tissues such as tumors or epileptic foci (29). Future clinical fMRI applications 
are anticipated in the diagnosis and monitoring of probable Alzheimer's disease, learning 
disabilities and other neurological disorders.   
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MATERIALS AND METHODS 
Subjects 
 
 The subjects included in this analysis are the initial recruits of a longitudinal study 
to examine the neural circuitry for reading from the beginnings of instruction to more 
advanced skill levels (ages 7.5-10.5) in non-impaired (NI) and reading disabled (RD) 
children. Eighteen children were recruited prospectively over a 6-month period.  The 
subjects were 8 boys (mean age at fMRI testing = 8 years and 2 months; SD = 6 months; 
range from 6 years, 9months to 10 years, 3 months) and 10 girls (mean age at fMRI 
testing = 7 years and 10 months; SD = 1 year; range from 7 years to 8 years, 9 months).  
The definition of reading disability (RD) is based on the Wechsler Intelligence Scale for 
Children-III (35) Full Scale IQ and the Decoding (Basic Reading cluster) score from the 
Woodcock-Johnson Psychoeducational Test Battery-Revised (36).  To participate in the 
study, all children had a Full Scale IQ of 75 or above on the WISC-III.  Children will be 
defined as RD on the basis of a score below the 21st percentile on the Basic Reading 
cluster of the Woodcock-Johnson.  This definition specifically excludes children who 
have reading scores that are discrepant with IQ, but who have reading scores above 
achievement cutoff (22nd percentile and higher).  Decoding definitions are used because 
of evidence that these measures most reliably and validly define the largest group of 
children with RD (37, 38, 39).  Each child was evaluated behaviorally, with MR 
spectroscopy, and with fMRI, at the time of recruitment.  The MRS and fMRI studies 
were performed on different days, not more than 2 months apart from each other. 
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1H Magnetic Resonance Spectroscopy 
MRS was performed with a 4-Tesla magnet with a 94-cm bore and a Bruker 
Avance spectrometer. GABA was detected using a spin-echo J-editing measurement (40). 
A surface coil was placed against the back of the head.  For voxel positioning, 
gradient-echo scout images with a nominal axial orientation were acquired from slices 
1.5 mm thick, with no slice gap and a field of view of 200 mm, divided into 128x128 
pixels.  For each measurement, the water signal was used to calibrate the pulse power for 
the spin-echo sequences and the selective inversion pulse used for the J-editing of 
GABA. 
The GABA-editing sequence was run in blocks of 22 minutes, yielding 27 
twenty-second pairs of sub-spectra that were subtracted to obtain the edited GABA 
signal.  Briefly, one sub-spectrum was acquired with an inversion pulse applied to the 
GABA C4 proton, and one sub-spectrum was acquired without the inversion pulse.  The 
phase of the coupled GABA C4 proton resonance was inverted in one sub-spectrum 
relative to the other, but the other, uncoupled, resonances in the region (e.g., creatine and 
choline) were the same in both spectra.  When the two-spectra were subtracted, creatine 
and choline vanish, leaving the GABA.  The data were acquired in interleaved fashion, 
toggling between individual inverted and uninverted acquisitions in 20-second blocks.  
Each block was stored and the sequence was run for 22 minutes to yield 27 pairs of sub-
spectra. Sub-spectra were acquired with 1024 data points in a 410-ms acquisition, a 3-
second repetition time, and a TE of 68 ms. 
To adjust for cortical atrophy, it is necessary to quantify the content of GM, WM, 
and CSF in the MRS voxel that was used for GABA detection.  The T1 relaxation rate of 
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gray matter, white matter, and CSF differ significantly, with values of 787 ± 47, 1236 ± 
69, and 3320 ± 325 ms at 4T (n=6, mean ± SD).  Therefore, T1 can be used to 
discriminate among the different tissue types in the brain, through image segmentation by 
tissue type.  To permit image segmentation, quantitative images of T1 were obtained 
using an inversion-recovery measurement with the surface coil in the same experimental 
session.  However, the surface coil has very inhomogeneous B1 that must be measured in 
addition to the inversion-recovery images.  
A B1 map (Figure 1) consisting of 7 contiguous 3-mm slices were acquired 
perpendicular to the short axis of the voxel, to span the 1.5-to-2 cm thickness of the 
occipital or frontal GABA voxels, or 14 3-mm slices to span the 4-cm thickness of the 
13C voxel.  For the GABA voxel, the 4 slices more distant from the coil were acquired 
using 3 dB less power than what is used for the 3 slices closest to the coil.  The different 
pulse powers were selected to yield a nominal flip angle of 40°-50° for each of the slices, 
whether near or far from the coil.  The sequence works by the acquisition of two gradient 
echo images obtained with pairs of sinc pulse excitations separated by 20-30 ms. The 
ratio of the images yields an image of the cosine of the individual excitation angles.  
Given the sinc pulse parameters of the amplitude, time, and shape, an image of the B1 
(Hz) was determined from the image of the excitation angle.  Because B1 varies slowly 
across space, the two sets of images were acquired with a 240-mm field of view and 64 x 
64 resolution, with a total acquisition time of 1.5 min.  
An inversion-recovery MRI was acquired with 3-mm slices to span the MRS 
voxels.  For GABA, 7 contiguous slices were acquired, with a 240 mm field of view and 
256 x 256 resolution, spanning the 1.5-cm voxel thickness, using rapid inversion-
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recovery sampling method (41) optimized statistically for sensitivity (42). Briefly, a 
single global inversion pulse was applied using a 3-lobe hyperbolic secant pulse (43) and 
gradient echo acquisitions of individual lines of k-space were acquired over two seconds 
following the inversion to sample the inversion recovery curve of the tissue water.  Due 
to overlap of slice excitation profiles, it is necessary to acquire half the slices in one set 
and the other half of the slices in another set.  For example, the 7-slice image set consists 
of two sets of excitations (slices 1, 3, 5, 7, and slices 2, 4, 6).  The total acquisition time 
for the quantitative T1 imaging and segmentation was 8 min for GABA.  
The paired images were processed using software written in MATLAB.  After 
Fourier-transformation, the first image of each pair was phased so that each pixel is 
purely real, and the identical phase was applied to the second image of each pair.  Basing 
the phasing of the second image on that of the first permits the identification of flip 
angles whose cosine is negative.  The ratio of the second image to the first yields an 
image of the cosine of the effective pulse angle in each image pixel of each slice, and the 
arc cosine of the image provides the effective pulse angle.  The effective pulse angle was 
converted to effective B1 based on a product-operator simulation of the frequency 
dependence of the pulse angle across the slice, thereby creating an image of B1 for each 
slice across the MRS voxel.  
After Fourier-transformation, the images were phased and, pixel-by-pixel, fitted 
with a simulation of the IR pulse sequence, using the B1 measured in the B1 maps.  The 
result of the fitting is a multi-slices set of quantitative images of T1.  The quantitative 
images of T1 were converted to images of percent GM, WM, and CSF (44), called graded 
segmented images.  From the segmented images and the known dimension and position 
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of the MRS voxel used for GABA detection, the composition of the MRS voxel was 
determined as percentages of GM, WM, and CSF based on an empirical calibration curve 
of mixtures of GM, WM, and CSF.  Figure 2 is an example of this procedure.  
Spectral Analysis 
Using software written in MATLAB (the Mathworks, Inc.), each sub-FID was 
phase-locked using the water FID and frequency-aligned using the resonances of NAA, 
creatine, and choline.  The two sub-FID’s were subtracted to obtain an FID of the edited 
GABA signal, and for inspection of subtraction quality were Fourier-transformed.  If 
patients moved during any of the GABA editing scans, the much larger and sharper Cr 
and Cho resonances caused well-defined subtraction errors that prevented the 
measurement of GABA, and any pairs of sub-spectra with such patient movement was 
not processed further.  The remaining, good-quality pairs were used to determine the area 
of the GABA resonance at 3ppm from the differences using LCModel (45).  LCModel 
was also applied to an averaged subspectrum from each measurement to determine the 
area of the resonance of creatine that lies at 3ppm, in addition to resonances of glutamate 
and glutamine.  The concentration of GABA was determined from the ratio of GABA 
and total creatine resonances according to the equation [GABA] = 
GABALCModel/CrLCModel x [Cr].  Assuming a creatine concentration varying linearly from 
6 to 9 mM/kg wet weight with tissue type (46), the concentrations of GABA, glutamate, 
and glutamine, NAA and choline were calculated from the concentration of creatine 
determined for the measured tissue composition.  The resonance areas of GABA, and the 
other metabolites were also measured as fractions of the resonance area of the 
unsuppressed water peak as an additional outcome that was provided by the LCModel 
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software.  Figures 4 and 5 exemplify spectra that were obtained after this analysis was 
performed.  
Functional Magnetic Resonance Imaging 
Functional magnetic resonance imaging (fMRI) was performed on a Siemens 
1.5T Sonata scanner located at the Yale University School of Medicine.  Subjects' heads 
were immobilized within a circularly polarized head coil by using a neck support, foam 
wedges, and a restraining band drawn tightly around the forehead.  Prior to functional 
imaging, 20 axial-oblique anatomic images (TE (echo time), 11 ms; TR (repetition time), 
420 ms; FOV (field of view), 20 x 20 cm; 6 mm slice thickness, no gap; 256 x256 x 1 
NEX (number of excitations)) were prescribed parallel to the intercommissural line based 
on sagittal localizer images (TE, 7.7; TR, 500 ms; FOV, 25.6 cm; 5 mm slice thickness, 
no gap; 256 x 256 x 1 NEX).  Activation images were collected using single shot, 
gradient echo, echo planar acquisitions (flip angle, 80 degrees; TE, 50 ms; TR, 2000 ms; 
FOV, 20 x 20 cm; 6 mm slice thickness, no gap; 64 x 64 x 1 NEX) at the same 20 slice 
locations used for anatomic images.  High-resolution anatomical images were obtained 
for 3-D reconstruction (Sagittal MPRAGE acquisition, flip angle, 8 degrees; TE, 3.65 ms; 
TR, 2000 ms; FOV, 25.6 x 25.6 cm; 1 mm slice thickness, no gap; 256 x 256 x 1 NEX; 
160 slices total).   
fMRI Task 
A cue—target identity task was employed in an event-related design that requires 
making a match/mismatch judgment with a button press. A picture cue is presented in the 
upper central portion of the display (e.g., a picture of a dog) and is replaced by another 
picture approximately every quarter of the imaging run. On each trial, participants 
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compare the picture with one of the following six types of stimuli: [1] high-frequency 
words, presented visually, [2] high-frequency words, presented auditorily; [3] 
pseudowords, presented visually, [4] pseudowords, presented auditorily; [5] consonant 
strings, presented visually and [6] words semantically-related to the cue, presented 
visually. The majority of trials (80%) are mismatches and only data from mismatch trials 
are included in analyses so that we can compare brain responses with a common (no) 
decision. Because picture cue remain on the screen for the duration of multiple trials, 
each new picture cue is treated as a trial condition and initially presented on the screen by 
itself, allowing sufficient time to model separately the evoked responses to processing of 
the picture cues.  For the fMRI session, 1090 full-brain images were collected across 10 
runs (3 min, 38 sec each); a total of 340 trials [240 ‘no’; 60 ‘yes’; 40 picture] were 
presented at jittered trial durations (4, 5, 6, 7 sec), with occasional longer durations (null 
trials). This results in 40 trials per condition for each of the six main stimulus types and 
40 trials for the picture condition. 
Data analysis was performed using software written in MATLAB (MathWorks, 
Natick, MA).  Images were first corrected for motion with SPM-99 (47) and sinc-
interpolated to correct for slice acquisition time.  For single-subject event-related 
analysis, a regression-based method was used, which allows direct estimation of the 
hemodynamic response for each trial type, at each voxel separately, without prior 
specification of a reference function (48, 49). Time course estimates were made for 1-sec 
intervals from -3 to +15 sec relative to trial onset. To create subject activation maps of 
the evoked response for each condition, we obtained regression estimates of the mean 
difference in these time course estimates for an activation period (3–8 sec after trial 
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onset) relative to a baseline period (0–3 sec prior to trial onset). Linear contrasts for 
effects of interest, including the evoked response of each trial type, simple subtractions 
among trial types, main effects, and interactions, were applied to these regression 
estimates to obtain contrast images for each subject. Across subjects, each voxel in these 
contrast images was tested versus zero with an F-test, implementing a mixed-model or 
repeated measures ANOVA (50, 51, 52).  Prior to across-subjects analysis, anatomic 
images and subject activation maps were transformed into a common proportional three-
dimensional grid (53), first by in-plane transformation and then by slice interpolation into 
the ten most superior slices of Talairach space, centered at z = +69, +60, +51, +42, +33, 
+23, +14, +5, -5, and -16 mm.   
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RESULTS 
The GABA levels from an occipital region of interest (ROI) (see Figure 3) as 
measured using MRS, ranged from a minimum of 1.619mM/kg to a maximum of 
2.128mM/kg (n=18).  The mean GABA level was 1.823mM/kg with a standard deviation 
(SD) of 0.135 mM/kg.  NAA levels from the same ROI ranged from a minimum of 
12.840mM/kg to a maximum of 17.000 mM/kg (n=18).  The mean NAA level was 
14.762mM/kg with a standard deviation (SD) of 1.296.  Table 1 provides the GABA, 
NAA levels and fMRI BOLD-activation scores for each of the 18 participants. There was 
a significant positive correlation between MRS-measured GABA and NAA levels in the 
occipital ROI, with a Pearson’s correlation of 0.479 (p<0.05, 2-tailed, n=18), as shown in 
figure 6. 
Figure 7 shows a color map of the composite fMRI BOLD response to a picture 
task in the 18 subjects. There is notable activation in slices 12-19 in the midline of the 
occipital lobe.  This area includes the anterior aspect of the lingual gyrus in the occipital 
lobe, with possible involvement of the posterior cingulate gyrus. There is also significant 
activation in a variety of brain regions, including the thalami, the lateral occipital gyri, 
posterior middle and superior temporal gyri, the inferior frontal gyrus bilaterally and the 
anterior cingulate gyrus. 
Figure 8 is a correlation map between GABA as measured by MRS and fMRI 
BOLD activation during picture processing in the midline of the occipital lobe. Using a 
Pearson’s correlation statistical analysis, a significant positive correlation (R=0.610, 
p=0.007, 2-tailed) was found between GABA levels and fMRI BOLD activation scores in 
more superior slices of the occipital lobe, presented as a scatter plot in figure 9.  The ROI 
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is slightly superior to the ROI used in the MRS study.  It includes the superior aspect of 
the occipital lobe and spans slices +16 to +21 (on z-axis of Talairach coordinate system), 
with an ROI volume of 26,484mm3 (i.e. 3.125mm by 3.125mm by 6mm and 452 
functional voxels) and radius of 18.75mm.  Other brain regions that demonstrate GABA 
and fMRI BOLD correlation include the thalamus bilaterally, the right posterior superior 
and middle temporal gyri, the inferior parietal lobule, the right superior frontal gyrus and 
the posterior cingulate gyrus.  
NAA also demonstrated a strong correlation with fMRI BOLD activation in the 
occipital lobe as seen in the color map representation in figure 10.  Using an ROI in more 
inferior slices of the occipital lobe that was slightly posterior to the MRS ROI, significant 
correlations (R=0.553, p=0.017, 2-tailed) are demonstrated in a scatter plot in Figure 11. 
The inferior slices span slices +7 to +11, with an ROI volume of 19,863mm3 (i.e. 
3.125mm by 3.125mm by 6mm and 339 functional voxels) and radius of 18.75mm.  
Other brain regions with BOLD and NAA correlation include the thalami bilaterally, the 
right inferior parietal lobule, and the left lateral occipital gyrus.    
The correlations obtained in Figures 9 and 11 utilized ROIs for the fMRI 
activation that were from a slightly different part of the occipital lobe compared with the 
ROI used for the MRS study.  We then used an ROI to obtain fMRI BOLD scores that 
was similar to the occipital ROI used in the MRS study.  Significant correlations were 
also found between both GABA (Figure 12) and NAA (Figure 13) levels and BOLD 
activation scores during picture processing in the region approximating the MRS ROI 
(59,590mm3 volume [i.e. 3.125mm by 3.125mm by 6mm and 1,017 functional voxels] 
and 18.75mm radius expanding from slices +7 to +21).  For GABA, the Pearson’s 
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correlation was 0.477 (p=0.045, 2-tailed), and for NAA the Pearson’s correlation was 
0.587 (p=0.01, 2-tailed).  No correlation was seen between BOLD activation and 
glutamate or choline.   
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DISCUSSION 
 
The present study investigated the interactions between MRS-measured 
metabolite levels and fMRI-BOLD activation in response to a picture-processing task 
performed on separate days and on different magnetic resonance systems. The findings 
indicate a positive correlation between GABA and NAA levels with fMRI BOLD 
activation, not only in the midline occipital ROI, but also in other regions of the brain.  
These results demonstrate that a major neurotransmitter, GABA, and a metabolite 
important to mitochondrial function in neurons, NAA, are linked to brain activation in 
children as they perform a cognitive task. As significantly more studies have been 
conducted using fMRI to study reading disability, this MRS-fMRI relationship also 
serves as an important validation for the role of future MRS studies in dyslexia and other 
cognitive processes.    
GABA and Learning 
The neurotransmitter measured in this study, GABA, is a widely distributed 
neurotransmitter in the central nervous system, with about sixty to eighty percent of 
neurons having GABA receptors.  GABA is the major inhibitory neurotransmitter in the 
brain, and together with glutamate - the major excitatory neurotransmitter, act to regulate 
general brain activation. It is important to note that although GABA is viewed as an 
inhibitory neurotransmitter, neurons that produce GABA (GABAergic neurons) may 
have complex effects following activation.   For instance, inhibitory neurons may be 
organized to provide negative feedback, leading to oscillatory interactions and the final 
effect of GABAergic neurons may be disinhibition. Inhibitory interneurons, by 
controlling the precise timing of firing of target cells, may also act to synchronize activity 
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among different neuronal populations (54). GABAergic neurons have been shown to 
participate in higher order CNS functions including learning, memory, emotions, etc.  It 
is recognized as playing a significant role in the generation of coherent neural networks, 
exemplified by the fact that the visual cortex (the dominant sensory input area) has about 
fifty percent more GABA neurons than other cortical areas. GABAergic neurons have 
also been implicated in playing a role in neuronal plasticity in response to functional 
changes. For instance Floyer-Lea et al. (55) using MRS found that motor sequence 
learning in humans significantly decreased GABA concentration by almost 20% in the 
contralateral primary sensorimotor cortex within a 2 x 2 x 2-cm3 voxel.  Enzymes 
involved in GABA synthesis were also altered in mouse cortex following sensory 
learning in a study by Gierdalski et al. (56).   In humans, benzodiazepines (GABA 
receptor antagonists) are mainly used as anticonvulsants and anxiolytics, but manifest 
memory impairment as a side effect.  
The role of GABA in learning and memory is also modeled in animal 
experiments, where benzodiazepines have been shown to impair spatial learning and 
memory (57).  And these deficits have been successfully reversed by flumazenil, a 
benzodiazepine antagonist (58).  Other studies in rats have shown that inverse agonists at 
specific GABA receptor subtypes enhance learning and memory (59, 60).   Clinically, 
Piracetam (a cyclic derivative of GABA) has been documented to improve various 
cognitive impairments (61), including reading disabilities. Given the extensive indirect 
evidence, among other researchers, the authors involved in this study have proposed that 
a balance in excitatory and inhibitory neural impulses in specific regions in the brain is 
necessary for successful development of reading skills.  And there is evidence to suggest 
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that the concentration of GABA in the cerebral cortex may be reflective of inhibitory 
neuron function, especially given that diseases such as depression, alcohol withdrawal 
and epilepsy, which alter GABA concentration also significantly affect inhibitory neural 
impulses in the brain (62, 63). In a separate arm of this study, the authors also test the 
hypothesis that polymorphisms of GABA-related genes may manifest in differences in 
GABA concentration in posterior language-related areas. 
The development of non-invasive measurement of GABA levels using MRS has 
been critical in investigating the link between GABA concentration and inhibitory 
neuronal function, and subsequently exploring how this link may relate to reading 
disorders.  However, GABA is difficult to measure in vivo using MRS for several 
reasons, including the fact that its small coupled spectral peaks are overlapped by much 
more intense resonances due to N-acetyl aspartate (NAA), creatine (Cr), and glutamate 
and glutamine (Glx) (27), resulting in increased complexity of the spectral analysis.  And 
although methods to edit out these other signals have been developed (in our study we 
used a selective inversion pulse), the separation of coupled from uncoupled resonances is 
not absolute. Various studies have nevertheless established the feasibility of GABA 
detection and measurement using MRS including, Oz’s group (64) who used a 4T 
magnet, STEAM MRS and LCModel to measure 10 metabolites, including GABA from 
the unilateral substantia nigra.  The GABA/Glu ratio they obtained in the substantia nigra 
compared to the cortex, was in excellent agreement with established neurochemistry (in 
post-mortem studies). Other studies using MRS to measure GABA levels have included 
one by McLean et al. (27), where the authors successfully measured in vivo levels of 
GABA and established a control range of GABA levels in the occipital lobes of volunteer 
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participants; Epperson et al. (66) - found GABA levels to be reduced in post-partum 
women in the occipital cortex, compared to age matched controls; Floyer-Lea’s group 
(55) - studied alterations in GABA concentration following motor learning.  The GABA 
range obtained in the current study (1.619mM/kg to a maximum of 2.128mM/kg) is in 
reasonable agreement with ex-vivo measurements of human cerebral GABA with 
concentration as high as 2.1mM/kg (66).  
GABA and fMRI 
Since its use in human experiments in the 1990s, several studies have been 
conducted to investigate the mechanism of the fMRI BOLD phenomenon. In general, 
these studies have concluded that fMRI does not directly measure neuronal activity, but 
relies on a signal, which results from changes in oxygenation, blood volume and flow – 
hence BOLD (blood oxygen level demand). Neurons require energy in other to maintain 
and restore membrane potentials that is necessary for signaling.  The primary source of 
energy for the brain is ATP created from glucose and oxygen, which are not stored in the 
brain and have to be replenished by continuous blood supply.  Therefore increases in 
neuronal activity result in increase in local energy demand, which results in increase in 
blood flow.  In other words, it is actually the metabolic demands of active neurons that 
are measured indirectly by fMRI (67). The metabolic demands of increased neuronal 
activity lead to an increase in oxygenated blood primarily from increased blood flow.  
More oxygen is supplied to the area than is extracted.  This results in a decrease in the 
amount of deoxygenated hemoglobin in the active brain region.  Oxygenated hemoglobin 
does not dephase protons in contrast to deoxygenated hemoglobin, which results in 
dephasing and signal loss.  The MR signal of a brain region during a task compared to a 
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baseline condition will therefore increase due to its relative increase in oxyhemoglobin 
compared with deoxyhemoglobin.   
The finding of a positive correlation between GABA and fMRI BOLD in 
response to the picture processing task in the current study provides evidence for the role 
of GABA in cognitive processes. Interestingly, 13C MRS studies in rats and humans have 
shown a one-to-one relationship between the metabolism of glucose in the tricarboxylic 
acid cycle and the cycling of neurotransmitters including GABA, which is released by 
neuronal firing and cycled via astrocytes through glutamine.  There is also a one-to-one 
relationship between the rate of glucose oxidation and neuronal firing.  Putting these 
together, it may be that the brain regions with appropriately developed GABAergic 
neuronal activity are capable of optimal functioning in response to cognitive tasks.  This 
is evidenced by the correlation of increased GABA levels with increased fMRI BOLD 
signal.  As discussed previously, Shaywitz et al. (5) have shown that higher reading skill 
correlates with stronger BOLD activation in the left hemisphere ventral cortex.  Thus 
although GABA levels were not studied in relation to reading skill in the current study, 
this result suggests, albeit tentative that such a relationship may exist.   
NAA and Neuroenergetics 
As discussed in the introduction, NAA is an indirect measure of neuronal 
integrity. The results in the current study found that higher NAA levels correlated with 
higher regional blood oxygen demand in the occipital MRS-ROI during a task.  The 
correlation of NAA and BOLD is supported by a study demonstrating that compared to 
healthy controls, schizophrenic patients tend to have low NAA levels in the prefrontal 
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cortex, which correlate with significantly lower increase in blood flow during cognitive 
tasks (68). 
A potential for NAA use clinically has been raised by studies showing that NAA 
appears to be reduced in bipolar disorder (a disorder with mood and cognitive deficits), 
and lithium (an effective treatment for bipolar disorder) has been reported to increase 
NAA levels.  Other clinical uses for NAA include the evaluation of diseases that destroy 
or injure neurons, like neoplasms, infection, stroke, demyelination or trauma.  These 
processes can lead to marked decreases in NAA levels.   
In general, NAA is widely used as a neuronal “marker” because of its relatively 
high concentration in neurons and its generation of a readily visible single peak on NMR 
spectra.  Increased NAA levels are generally believed to represent an increased number 
of intact neurons.  However, the MRS-fMRI relationship seen with NAA may be more 
complex, given the potential role of NAA in metabolism, neuroenergetics and ultimately 
cognitive processes. Shulman & Rothman (69) summarized from studies in their book 
that although the exact biological function of NAA is still unknown, its slow leak and 
small quantity release from neurons is inconsistent with a neurotransmitter function. One 
author proposed that NAA aids transportation of water across the hydrophobic myelin 
sheath during axonal firing (74), enabling more rapid and synchronized neuronal 
conduction, and thus better cognitive performance (21).   As an indicator of neuronal 
integrity, a study (70) demonstrated that NAA not only correlates with neuronal loss in 
animal models of stroke, but also with neuronal dysfunction.  NAA’s role in energy 
metabolism and brain function is supported by the fact that it is synthesized by a 
mitochondrial enzyme (71). Animal experiments have shown a significant correlation 
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between ATP loss and NAA levels following traumatic brain injury, consistent with a 
role for NAA in neuroenergetics (72).  In addition, O’Neill et al’s (73) PET/MRS study 
demonstrated a positive correlation between the in vivo rate of glucose utilization and the 
level of NAA. The fact that the fMRI-BOLD signal is indirectly reflective of energy 
metabolism and NAA has also been implied in neuroenergetics suggests a key 
relationship.  In summary, the current study demonstrates that the fMRI signal during a 
task is directly correlated with NAA, which is a marker of neuronal function and is 
involved in neuronal energy metabolism.  NAA levels thus appear to be important for 
brain function during cognitive tasks.   
GABA-NAA Relationship 
An explanation for the positive correlation between GABA and NAA (Figure 6) is 
the fact that as presented above, NAA has been shown to correlate with neuronal volume.  
Therefore, areas of the brain with increased GABAergic neuronal density will be 
expected to have increased NAA levels and vice-versa.  However, NAA is more directly 
implicated in glutamate cycling.  But glutamate is also a GABA precursor and NMR 
studies indicate that GABA and glutamine cycling is an important part of GABA 
production.  Through its role in mitochondrial energetics in glutamine cycling, NAA may 
be an indirect correlate of GABA neurotransmitter production and release.   
This is also suggested in epilepsy studies, where brain regions involved in 
epilepsy have lower NAA levels, indicating suboptimal mitochondrial energetic function.  
There is also increased extracellular glutamate and a decreased rate of glutamate 
recycling.  
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Conclusion   
The preliminary results obtained in this study indicate a significant correlation 
between metabolic and hemodynamic measures in cognitive processes using two 
important magnetic resonance diagnostic modalities, MRS and fMRI.  The results also 
support the potential role for GABA in reading (dis)ability, which has important 
implications for understanding the pathophysiology and also in drug development and 
research.  It also raises the possibility for the role of NAA as an adjunct in fMRI studies 
and as a potential biomarker in cognitive disorders.  It is important to conduct additional 
studies in this area to further explore and confirm these findings.    
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Figure 3:  Localizer images in axial, sagittal and coronal planes demonstrating 
location of voxel used for MRS measurements.  The voxel was 3 cm right to left, 3 
cm superior to inferior and 1.5 cm anterior to posterior
Figure 1. B1 images.  To image the RF inhomogeneity as a B1 image, the two 
images are acquired with a delay of 51 ms between the two acquisitions using the 
same pulse angle (left and center).  The 2nd image is proportional to the first by 
the cosine of the excitation angle.  The pulse angle image can then be converted 
to an image of B1 (far right). (75) 
Figure 2. Imaging of T1 and tissue type.  After an inversion pulse is applied, a series of 
images is acquired to track the T1 recovery of the water magnetization (top row).  Least-
squares fitting is performed using a numerical simulation of the pulse sequence to obtain 
an image of the T1 values (instead of a T1-weighted image) (bottom left).  The T1 values 
are used to determine the percentage of WM, GM, and CSF in each pixel (bottom right 3 
images). (75) 
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Figure 5: Cortical GABA detected by J-editing. GABA, gamma-aminobutyric
GABA 
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Figure 4: MRS measurements of brain metabolites.   NAA, N-acetyl 
aspartate. Glx, glutamate and glutamine.  Cr, creatine.  Ch, choline.   
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Figure 7.  Composite fMRI BOLD response to pictures in 18 subjects., p = 0.05.   
Note activation in the midline of the lingual gyrus on slices 12-19. 
Figure 6: Correlation between MRS measured NAA and GABA levels from 
the occipital ROI of Figure 3.  R=0.479 (p=0.044, 2-tailed, n= 18) 
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Figure 8: Correlation map between GABA levels and BOLD activation scores 
during picture processing.  p<0.01, 2-tailed.  
Figure 9: Correlation between GABA level and BOLD activation scores during 
picture processing using an occipital ROI placed in slices 16-21 in Figure 8.
R=0.610, p=0.007, 2-tailed. ROI volume of 26,484mm3 and 18.75mm radius. 
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Figure 10: Correlation map between NAA levels and BOLD activation scores 
during picture processing.  P<0.01, 2-tailed.  
Figure 11: Correlation between NAA level and BOLD activation scores during 
picture processing using an occipital ROI placed in slices 7-12 in Figure 10.
R=0.553, p=0.017, 2-tailed. ROI volume of 19,863mm3 and 18.75mm radius.  
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Figure 12: Correlation between MRS measured GABA levels and fMRI 
BOLD activation scores during picture processing from an occipital ROI 
similar to the MRS ROI in Figure 3.  R=0.477 (p=0.045, 2-tailed). fMRI ROI = 
volume of 59,590mm3 and 18.75mm radius from slices +7 to +21.  
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Figure 13: Correlation between MRS measured NAA levels and fMRI BOLD 
activation scores during picture processing from an occipital ROI similar to 
the MRS ROI in Figure 3. R=0.587 (p=0.01, 2-tailed). fMRI ROI = volume of 
59,590mm3 and 18.75mm radius from slices +7 to +21.  
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Table 1: GABA and NAA concentrations from midline occipital ROI as measured by MRS,
and BOLD fMRI scores. Mean GABA level =1.823, SD =  0 .135.  Mean NAA level = 14.672,
SD = 1.296 (n=18).
Participant
# Gender
Age at
fMRI
testing
(yr)
GABA
(mM/kg)
NAA
(mM/kg)
Superior
slices
BOLD
Inferior
Slices
BOLD
"MRS
ROI"
BOLD
1 M 8.0 2.128 16.07 1.166900 1.43390 1.29880
2 F 7.8 1.644 14.57 0.021051 0.74152 0.37761
3 F 8.3 1.788 12.93 0.238820 0.13621 0.12027
4 F 7.7 1.806 15.64 0.344680 0.13508 0.21367
5 F 8.2 1.838 15.50 0.467240 0.59854 0.65097
6 F 7.0 1.764 14.44 1.676600 1.74680 1.70540
7 M 6.8 1.662 14.74 -0.913770 -0.23254 -0.61759
8 F 8.4 1.947 16.82 1.350400 0.10265 0.95373
9 M 7.6 1.933 13.50 1.826600 -1.01470 0.55795
10 F 8.8 1.917 17.00 0.610750 1.96570 1.21730
11 M 10.3 1.879 16.41 0.060588 0.91072 0.42578
12 F 7.4 1.750 14.38 -0.377120 -0.43925 -0.41757
13 M 9.0 1.619 13.99 -0.366840 -0.19705 -0.17445
14 M 7.9 1.833 13.36 -1.030500 -0.72188 -0.84625
15 F 8.3 1.665 13.45 -0.492940 -0.03167 -0.25903
16 M 7.6 1.827 12.84 -1.027100 -3.53450 -2.21390
17 M 8.1 2.029 15.35 2.015100 0.93011 1.74060
18 F 7.2 1.790 14.73 -1.164000 -1.11290 -1.19000
